Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
This study is ongoing, but not recruiting participants.
Study NCT00069940   Information provided by National Cancer Institute (NCI)
First Received: October 3, 2003   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastrointestinal Stromal Tumor
Sarcoma
Additional conditions recognized in this trial
Brain Neoplasms
Central Nervous System Neoplasms
Gastrointestinal Stromal Tumors
Nervous System Neoplasms
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Nervous System Diseases
Interventions listed in this trial
sargramostim
telomerase: 540-548 peptide vaccine
Sponsors listed in this trial
Dana-Farber Cancer Institute
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services